Hanson Bryan C

Average Profitability
5.73%
Insider Buys Quantity
6
Insider Buys Sum
$6.83M
Insider Sells Quantity
10
Insider Sells Sum
$17.31M

Insider Activity of Hanson Bryan C

The largest purchase of all time was on 2018-02-15 and amounted to 49034 shares of Zimmer Biomet Holdings, Inc. for $5.87M.

The largest sale of all time was on 2017-12-15 and amounted to 32000 shares of Medtronic plc for $2.65M.

Biography of Hanson Bryan C

No biography is available at this moment.

2020-05-13PurchaseZimmer Biomet Holdings, Inc.
ZBH
President and CEO
2,000
0.001%
$113.00$226,000+32.2%
2019-02-07PurchaseZimmer Biomet Holdings, Inc.
ZBH
President and CEO
4,200
0.0021%
$119.02$499,872+14.1%
2018-08-31PurchaseZimmer Biomet Holdings, Inc.
ZBH
President and CEO
820
0.0004%
$123.03$100,885-0.98%
2018-02-20PurchaseZimmer Biomet Holdings, Inc.
ZBH
President and CEO
30
<0.0001%
$119.86$3,596-2.88%
2018-02-16PurchaseZimmer Biomet Holdings, Inc.
ZBH
President and CEO
1,090
0.0005%
$119.38$130,121-4.29%
2018-02-15PurchaseZimmer Biomet Holdings, Inc.
ZBH
President and CEO
49,034
0.0241%
$119.69$5.87M-3.74%
2017-12-15SaleMedtronic plc
MDT
EVP, President, MITG
32,000
0.0023%
$82.82$2.65M+4.96%
2017-11-16SaleMedtronic plc
MDT
EVP, President, MITG
32,000
0.0024%
$79.02$2.53M+9.58%
2017-10-16SaleMedtronic plc
MDT
EVP, President, MITG
32,000
0.0024%
$78.03$2.5M+10.38%
2017-07-17SaleMedtronic plc
MDT
EVP, President, MITG
24,000
0.0018%
$88.57$2.13M-4.32%
2016-08-29SaleMedtronic plc
MDT
EVP, President, MITG
30,000
0.0014%
$58.26$1.75M-4.58%
2016-07-26SaleMedtronic plc
MDT
EVP, President, MITG
30,000
0.0014%
$58.26$1.75M-5.11%
2016-07-05SaleMedtronic plc
MDT
EVP, President, MITG
30,544
0.0014%
$57.20$1.75M-3.33%
2016-03-04SaleMedtronic plc
MDT
EVP, President, MITG
10,000
0.0007%
$75.00$750,000+8.64%
2016-02-05SaleMedtronic plc
MDT
EVP, President, MITG
10,000
0.0007%
$76.14$761,400+9.44%
2016-01-08SaleMedtronic plc
MDT
EVP & Pres Min Invas Therapies
10,000
0.0007%
$75.00$750,000+10.45%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.